A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.
New multi-polygenic scores boost coronary heart disease prediction accuracy
Two multi-polygenic scores (muti-PGs) to predict coronary heart disease (CHD).